Impact Biomedical (IBO) Depreciation and Depletion (2023 - 2025)
Impact Biomedical (IBO) posted Depreciation and Depletion of $2000.0 for Q4 2025, up 100.0% on a QoQ basis from $1000.0 in Q3 2025, and little changed year-over-year from $2000.0 in Q4 2024.
Impact Biomedical (IBO) Depreciation and Depletion (2023 - 2025) Analysis & Trends
Impact Biomedical's Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $2000.0 for Q4 2025.
- Quarterly Depreciation and Depletion changed 0.0% year-over-year to $2000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6000.0 (down 14.29% YoY) and the FY2025 annual result came in at $6000.0, down 14.29% from the prior year.
- Depreciation and Depletion was $2000.0 for Q4 2025 at Impact Biomedical, up from $1000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $2000.0 in Q1 2023 and bottomed at $1000.0 in Q2 2023.
- A 3-year average of $1583.3 and a median of $2000.0 in 2023 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2024 — Depreciation and Depletion surged 100.0% — and 2025, when it plunged 50.0%.
- Impact Biomedical's Depreciation and Depletion stood at $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
- Business Quant data shows IBO's Depreciation and Depletion at $2000.0 in Q4 2025, $1000.0 in Q3 2025, and $2000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |